Unifiram (CAS 272786-64-8, DM – 232) is a high – purity nootropic agent API with a targeted cognitive – enhancing mechanism. It acts as a positive allosteric modulator of AMPA receptors, promoting acetylcholine release in the cerebral cortex, enhancing synaptic plasticity and improving learning and memory functions. It shows potent antiamnesic effects in animal studies, with far higher potency than traditional nootropics like piracetam. It is mainly used for the research of cognitive impairment – related neurological disorders and cognitive enhancement drug development. Its refined powder form ensures stable bioactivity and low impurity levels, making it a reliable active ingredient for neuroscience pharmaceutical R&D.